Detalles de la búsqueda
1.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906039
2.
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer.
Int J Clin Pharm
; 46(2): 382-389, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112892
3.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
Clin Genitourin Cancer
; 21(3): e166-e174, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610891
4.
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study.
Eur Urol Oncol
; 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838555
5.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Target Oncol
; 14(1): 15-32, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30694442
6.
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 37(6): 490-503, 2019 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625039
7.
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma.
BMC Pharmacol Toxicol
; 19(1): 77, 2018 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477570
8.
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies.
Expert Opin Drug Saf
; 17(6): 573-579, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28535693
9.
Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.
Eur J Cancer
; 87: 30-37, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29102858
10.
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Eur J Cancer
; 75: 73-82, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28222309
Resultados
1 -
10
de 10
1
Próxima >
>>